glicentin has been researched along with Obesity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 6 (85.71) | 2.80 |
Authors | Studies |
---|---|
Angelidi, AM; Gavrieli, A; Kokkinos, A; Mantzoros, CS; Perakakis, N; Tentolouris, N; Tsilingiris, D; Yannakoulia, M | 1 |
Argyrakopoulou, G; Kalra, B; Kokkinos, A; Konstantinidou, SK; Kouvari, M; Kumar, A; Mantzoros, CS; Simati, S; Stefanakis, K | 1 |
Alexandrou, A; Ghaly, W; Kokkinos, A; Mantzoros, CS; Peradze, N; Perakakis, N; Pilitsi, E; Tentolouris, N; Upadhyay, J | 1 |
Anastasilakis, AD; Boutari, C; Ghaly, W; Karagiannis, A; Kountouras, J; Mantzoros, CS; Perakakis, N; Polyzos, SA | 1 |
Holst, JJ; le Roux, CW; Nielsen, MS; Ritz, C; Sjödin, A; Wewer Albrechtsen, NJ | 1 |
Farr, OM; Mantzoros, CS; Perakakis, N | 1 |
Birkenfeld, AL; Dannecker, C; Fritsche, A; Fritsche, L; Häring, HU; Heni, M; Hoene, M; Hummel, J; Kantartzis, K; Machann, J; Peter, A; Stefan, N; Vosseler, A; Wagner, R; Weigert, C | 1 |
2 trial(s) available for glicentin and Obesity
Article | Year |
---|---|
Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Topics: Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Lipids; Obesity; Overweight; Oxyntomodulin; Peptides; Proglucagon | 2022 |
Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.
Topics: Adult; Bariatric Surgery; Female; Gastrointestinal Hormones; Glicentin; Humans; Male; Middle Aged; Obesity; Oxyntomodulin; Postprandial Period; Predictive Value of Tests; Prognosis; Weight Loss | 2019 |
5 other study(ies) available for glicentin and Obesity
Article | Year |
---|---|
Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.
Topics: Blood Glucose; Female; Glicentin; Glucagon; Humans; Male; Meals; Obesity; Peptides; Postprandial Period; Proglucagon; Thinness | 2023 |
Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
Topics: Adult; Biomarkers; Biopsy; Case-Control Studies; Disease Progression; Female; Follistatin-Related Proteins; Glicentin; Glucose Tolerance Test; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Proglucagon; Severity of Illness Index; Somatomedins | 2020 |
Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
Topics: Adult; Bariatric Surgery; Biomarkers; Case-Control Studies; Energy Intake; Female; Follow-Up Studies; Food Preferences; Gastrectomy; Gastric Bypass; Glicentin; Humans; Male; Obesity; Oxyntomodulin; Peptide YY; Prognosis; Weight Loss | 2020 |
Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study.
Topics: Adult; Attention; Brain; Cross-Sectional Studies; Cues; Fasting; Gastric Inhibitory Polypeptide; Glicentin; Humans; Magnetic Resonance Imaging; Obesity; Oxyntomodulin; Reward | 2021 |
Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation.
Topics: Adult; Body Weight; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glicentin; Humans; Male; Middle Aged; Obesity; Oxidation-Reduction | 2021 |